Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Antiphospholipid antibodies and vascular thrombosis in patients with severe forms of COVID-19
Mirjana Zlatković Švenda, Mirjana Zlatković Švenda, Milica Ovuka, Manca Ogrič, Saša Čučnik, Polona Žigon, Aleksandar Radivčev, Marija Zdravković, Goran Radunović
Izvirni znanstveni članek
Oznake: COVID-19;antiphospholipid syndrome;vascular thrombosis;antiphospholipid antibodies;anticardiolipin antibodies (aCL);anti-β2-glycoprotein I antibodies (anti-β2GPI);anti-phosphatidylserine-prothrombin (aPS/PT) antibodies;
Antiphospholipid antibodies (aPLA) are a laboratory criterion for the classification of antiphospholipid syndrome (APS) and are known to cause clinical symptoms such as vascular thrombosis or obstetric complications. It is suggested that aPLA may be associated with thromboembolism in severe COVID-19 ...
Leto: 2023 Vir: Repozitorij Univerze v Ljubljani (RUL)
Longitudinal analysis of antiphospholipid antibody dynamics after infection with SARS-CoV-2 or vaccination with BNT162b2
Manca Ogrič, Polona Žigon, Snežna Sodin-Šemrl, Mirjana Zlatković Švenda, Marija Zdravković, Milica Ovuka, Tinka Švec, Katja Lakota, Peter Radšel, Žiga Rotar, Saša Čučnik
Izvirni znanstveni članek
Oznake: COVID-19;SARS-CoV-2;BNT162b2 cepivo;avtoprotitelesa;antifosfolipidna protitelesa;profesionalizem v zdravstveni oskrbi;APS;BNT162b2 vaccine;autoantibodies;antophospholipid antibodies;healthcare professionalism;
Antiphospholipid antibodies (aPL) comprise a group of autoantibodies that reflect prothrombotic risk in antiphospholipid syndrome (APS) but may also be present in a small proportion of healthy individuals. They are often transiently elevated in infections, including SARS-CoV-2, and may also be assoc ...
Leto: 2023 Vir: Medicinska fakulteta (UL MF)
ǂThe ǂnew occurrence of antiphospholipid syndrome in severe COVID-19 cases with pneumonia and vascular thrombosis could explain the post-COVID syndrome
Mirjana Zlatković Švenda, Melanija Rašić, Milica Ovuka, Slavica Pavlov Dolijanović, Marija Atanasković Popović, Manca Ogrič, Polona Žigon, Snežna Sodin-Šemrl, Marija Zdravković, Goran Radunović
Izvirni znanstveni članek
Oznake: COVID-19;SARS-CoV2;anti-phosphatidylserine-prothrombin (aPS/PT) antibodies;anti-β2-glycoprotein I (anti-β2GPI) antibodies;anticardiolipin (aCL) antibodies;antiphospholipid antibodies (aPLs);antiphospholipid syndrome;immunology;post-COVID syndrome;vascular thrombosis;
Introduction: The classification of antiphospholipid syndrome (APS) comprises clinical criteria (vascular thrombosis or obstetric complications throughout life) and laboratory criteria (antiphospholipid antibodies (aPLs) positivity, confirmed at least twice at 12-week interval). Methods: In 100 pati ...
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: